Why Stem Cells Work Best For Cerebral palsy

Extensive research has led to the conclusion that transplantation of autologous stem cells is a promising treatment to improve and reverse neurological and muscular damages and also prevent secondary complications from arising.  

Cell treatment, employed at Neurogen BSI to treat patients with cerebral palsy, has shown promising results. They employ autologous mesenchymal stem cells (extracted from the bone marrow) to treat cerebral palsy patients. The potential of mesenchymal cell treatment are:

1. Reduce the inflammatory reaction
2. Avoid secondary brain lesion
3. Can differentiate into neurons, microglia, and astrocyte to promote axon regeneration, and repair the myelin sheath
4.  Produce cytokines and nerve growth factors, to promote neuroprotection
5. Generate new blood vessels and thus, increase sufficient oxygen and nutrient supply to the injured tissue
6. Reduce intrinsic cell apoptosis

Cerebral palsy treatment in India’s Neurogen BSI provides easy access to patients with cerebral palsy. They provide the best treatment plans that begin with extensive medical evaluation and a complete treatment understanding which involves stem cells. The service here is provided by the best neurosurgeons and trained staff. 

Promising Improvements

Treatment for cerebral palsy, using a combination of cell therapy and supportive or rehabilitation therapies, have shown visible improvements in patients. Cerebral palsy treatment in India has helped to regain motor development and limb coordination, recover impaired vision and cognitive skills, increase muscle strength, and decrease spasticity. A notable improvement is also seen in fine and gross motor skills due to improved muscle tone.

Cerebral Palsy treatment with stem cells has proved an improvement in areas such as:

• Motor function
• Limb coordination
• Eyesight 
• Muscular Strength
• Epilepsy
• Swallowing
• Communication skill 

Moreover, treatment with stem cells releases the growth factors which promote cell growth, regulates immune response, and stimulation the brain cells to accelerate recovery of brain plasticity.

Supportive Therapies 

After cell therapy, neurosurgeons also prescribe supportive therapies or immune-enhancing programs to get the most out of the infused stem cells. Some of the programs included in the agenda are:

• Hyperbaric Oxygen Chamber (HBOT)
• Occupational therapy
• Aquatic therapy
• Physiotherapy treatment
• Special diet plans 
• Psychological intervention

 The staff at Neurogen BSI believe that each visiting patient (with cerebral palsy or other neurodegenerative disorders) deserve an effective and safe treatment. They provide the next-generation treatments, within the best in-house facilities and services that are integrative to ensure the best possible treatment results.

Mesenchymal Stem Cells - An Anti-Inflammatory Treatment for Muscular Dystrophy

Duchenne muscular dystrophy is a progressive and lethal muscular-degenerative condition which is caused by the mutation of the dystrophin gene. Cell therapy for muscular dystrophy is the only intervention that can mediate improvement in patients. 

Without the essential dystrophin, muscle fibres are highly vulnerable to damage and easy succumbing, affecting the normal daily activities in patients.  This muscle damage is easily repaired with autologous mesenchymal stem cells that have the potential to address this progressive degeneration in muscular dystrophy muscles. Thus, cell transplantation is the best muscular dystrophy treatment approach to reverse the damage of degenerated muscle-cells in patients with muscular dystrophy.

Mesenchymal stem cells are multipotent cells that can be easily sourced from the marrow tissue. They have the capacity to repair bone, brain cell tissue, blood vessel, and muscular-skeletal tissue. These cells have shown great promise for patients with muscular dystrophy in NeuroGen BSI hospital where the neurosurgeons confirm the safety of muscular dystrophy treatment with intrathecal injection of mesenchymal stem cells in the spinal area.

The trained surgeons and staff at the NeuroGen BSI  have stated amazing symptomatic improvement in 90% of their muscular dystrophy patients.  They have a vast experience of treating individuals with degenerative muscle diseases, spinal cord injury and those disturbed with neurological conditions. Thus, mesenchymal cell therapy for muscular dystrophy is an emerging regenerative medicine that focuses on treatment providing improved limb and muscle coordination.

People who inquire about the advantage of cell treatment with mesenchymal stem cells (in contrast to other cell-based therapies) must know the underlying benefits:  

• The ability to fuse and genetically balance dystrophic deficiency in muscle
• They possess anti-inflammatory factors
• They produce trophic factors that enhance the activity of cell repair

With the above-mentioned properties, the neurosurgeons prefer mesenchymal stem cell therapy for muscular dystrophy as they have the advantages of correcting the dystrophin deficiency in muscle cells and also in regaining the muscle tone, flexibility, strength and a balanced gait.